HeartBeam, Inc.(BEAT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
BEAT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for HeartBeam, Inc. (BEAT), a Healthcare sector company. BEAT is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), HeartBeam, Inc. reports net income of $-4.7M, free cash flow of $-3.9M. Top institutional holders of BEAT by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, BlackRock,, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. BEAT trades on the Nasdaq exchange and files with the SEC under CIK 1779372. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BEAT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HeartBeam, Inc. directly from SEC EDGAR.
Net Income
Q1 2026
$-4.7M
Free Cash Flow
Q1 2026
$-3.9M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Net Income
-32.9% YoYOperating Income
-29.9% YoYEPS (Diluted)
-1.4% YoYTotal Assets
-80.9% YoYOp. Cash Flow
-19.7% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Net Income | $-19.4M -32.9% | $-14.6M -12.9% | $-13.0M -192.7% | $-4.4M | — |
| Operating Income | $-19.9M -29.9% | $-15.3M -17.5% | $-13.0M -470.3% | $-2.3M | — |
| EPS (Diluted) | $-0.73 -1.4% | $-0.72 +54.7% | $-1.59 -54.4% | $-1.03 | — |
| Total Assets | $3.3M -80.9% | $17.1M +324.1% | $4.0M -71.1% | $14.0M | — |
| Operating Cash Flow | $-14.5M -19.7% | $-12.1M -21.6% | $-9.9M -208.0% | $-3.2M | — |
AI Insight: BEAT Financial Trends
HeartBeam remains unprofitable with consistent $5M quarterly net losses and minimal equity cushion eroding to $1M by Q1 2026.
• Operating cash burn stabilized at $3–4M per quarter since Q2 2025, improving from $4M in Q4 2024.
• Equity declined 89% from $9M (Q2 2024) to $1M (Q1 2026), raising solvency concerns.
⚠ Equity at $1M in Q1 2026 — company approaching insolvency; further losses threaten going concern.
⚠ No revenue visible across eight quarters — product commercialization or financing critical within months.
AI Insight: BEAT Ratio Trends
Insufficient data to assess HeartBeam's financial trends — all ratio metrics are missing across all periods.
• No operating margin, net profit margin, ROE, ROA, ROIC, or debt-to-equity figures available for analysis.
⚠ Data collection or reporting gap prevents evaluation of profitability, efficiency, and leverage trends.
Get alerted when BEAT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for HeartBeam, Inc. including:
Top Institutional Holders of BEAT
VANGUARD CAPITAL MANAGEMENT LLC
$1.5M1,197,793 shBlackRock, Inc.
$1.1M898,321 shGEODE CAPITAL MANAGEMENT, LLC
$460.3K377,212 shSmith, Salley & Associates
$448.5K367,647 shUBS Group AG
$408.9K335,189 shBeacon Pointe Advisors, LLC
$301.9K247,458 shO'SHAUGHNESSY ASSET MANAGEMENT, LLC
$254.0K208,191 shRITHOLTZ WEALTH MANAGEMENT
$254.0K208,191 shKESTRA PRIVATE WEALTH SERVICES, LLC
$212.2K173,939 shVANGUARD FIDUCIARY TRUST CO
$183.1K150,062 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.5M | 1,197,793 |
| BlackRock, Inc. | $1.1M | 898,321 |
| GEODE CAPITAL MANAGEMENT, LLC | $460.3K | 377,212 |
| Smith, Salley & Associates | $448.5K | 367,647 |
| UBS Group AG | $408.9K | 335,189 |
| Beacon Pointe Advisors, LLC | $301.9K | 247,458 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $254.0K | 208,191 |
| RITHOLTZ WEALTH MANAGEMENT | $254.0K | 208,191 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $212.2K | 173,939 |
| VANGUARD FIDUCIARY TRUST CO | $183.1K | 150,062 |
More Healthcare Companies
View all Healthcare →Put BEAT on your watchlist
Track score changes the day HeartBeam, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BEAT a good stock to buy?
13F Pro's AI-powered analysis of HeartBeam, Inc. (BEAT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BEAT are available on the BEAT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own BEAT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BEAT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HeartBeam, Inc.'s investment landscape.